The Innovation Growth Program (IGP) grant allows Botanist Biopharma to develop, validate, and bring to market a completely novel, yet essential Precision Pharma-Grade Oral Cannabis Oil product line that is currently not available to Manitoban, Canadian, or International medical cannabis patients.